Back to Search
Start Over
Subsequent anti‐myeloma therapy after maturation antigen ( <scp>BCMA</scp> ) chimeric antigen receptor ( <scp>CAR</scp> )‐T cell ( <scp>HDS269B</scp> ) treatment in patients with relapsed/refractory multiple myeloma
- Source :
- American Journal of Hematology. 97
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Hematology
Subjects
Details
- ISSN :
- 10968652 and 03618609
- Volume :
- 97
- Database :
- OpenAIRE
- Journal :
- American Journal of Hematology
- Accession number :
- edsair.doi...........df95e2f8fdc726f393eb1e2b9689ecd3